D
Patient 1
(B)(4). IT WAS REPORTED BY THE PT'S ATTORNEY THAT AS A RESULT OF HAVING THE PRODUCT IMPLANTED, THE PT HAS EXPERIENCED INJURY, PAIN, DISABILITY AND IMPAIRMENT.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PELVILACE BIOURETHRAL SUPPORT SYSTEM | TISSUE SCIENCE LABORATORIES | FTM | NA | 482150 | CVTH0026 | R | N |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2013-09-12 | 0 | 1. R |
Patient 1
(B)(4). IT WAS REPORTED BY THE PT'S ATTORNEY THAT AS A RESULT OF HAVING THE PRODUCT IMPLANTED, THE PT HAS EXPERIENCED INJURY, PAIN, DISABILITY AND IMPAIRMENT.
Patient 1
THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE (IFU) WHICH ACCOMPANIES THIS DEVICE CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. (B)(4).